Drugs / [F-18]Florastamin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05004285 | Apr 2021 → Jun 2025 overdue | prostate cancer | FutureChem | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [F-18]Florastamin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05004285 ↗ |
| Modality | Diagnostic / imaging agent | “PET/CT Imaging Diagnosis” NCT05004285 ↗ |
| Route | Intravenous | “is IV administered” NCT05004285 ↗ |